JPWO2021041989A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021041989A5 JPWO2021041989A5 JP2022513477A JP2022513477A JPWO2021041989A5 JP WO2021041989 A5 JPWO2021041989 A5 JP WO2021041989A5 JP 2022513477 A JP2022513477 A JP 2022513477A JP 2022513477 A JP2022513477 A JP 2022513477A JP WO2021041989 A5 JPWO2021041989 A5 JP WO2021041989A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibody
- days
- treating
- single dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962893747P | 2019-08-29 | 2019-08-29 | |
US62/893,747 | 2019-08-29 | ||
US202062993519P | 2020-03-23 | 2020-03-23 | |
US62/993,519 | 2020-03-23 | ||
US202063040966P | 2020-06-18 | 2020-06-18 | |
US63/040,966 | 2020-06-18 | ||
PCT/US2020/048635 WO2021041989A1 (en) | 2019-08-29 | 2020-08-28 | Compositions and methods for treatment of influenza a infection |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022545553A JP2022545553A (ja) | 2022-10-27 |
JPWO2021041989A5 true JPWO2021041989A5 (zh) | 2023-09-04 |
Family
ID=72473986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022513477A Pending JP2022545553A (ja) | 2019-08-29 | 2020-08-28 | A型インフルエンザ感染の治療のための組成物及び方法 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20220306728A1 (zh) |
EP (1) | EP4021502A1 (zh) |
JP (1) | JP2022545553A (zh) |
KR (1) | KR20220061999A (zh) |
CN (1) | CN115052630A (zh) |
AU (1) | AU2020335922A1 (zh) |
BR (1) | BR112022003529A2 (zh) |
CA (1) | CA3148990A1 (zh) |
IL (1) | IL290752A (zh) |
MX (1) | MX2022002447A (zh) |
WO (1) | WO2021041989A1 (zh) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
EP0861893A3 (en) | 1991-09-19 | 1999-11-10 | Genentech, Inc. | High level expression of immunoglobulin polypeptides |
US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
KR100797667B1 (ko) | 1999-10-04 | 2008-01-23 | 메디카고 인코포레이티드 | 외래 유전자의 전사를 조절하는 방법 |
WO2004076677A2 (en) | 2003-02-26 | 2004-09-10 | Institute For Research In Biomedicine | Monoclonal antibody production by ebv transformation of b cells |
US9347043B2 (en) | 2008-10-22 | 2016-05-24 | Institute For Research In Biomedicine | Methods for producing antibodies from plasma cells |
US20140294812A1 (en) * | 2013-03-15 | 2014-10-02 | Xencor, Inc. | Fc variants that improve fcrn binding and/or increase antibody half-life |
SG11201805001UA (en) * | 2016-01-13 | 2018-07-30 | Medimmune Llc | Method of treating influenza a |
-
2020
- 2020-08-28 EP EP20771696.0A patent/EP4021502A1/en active Pending
- 2020-08-28 WO PCT/US2020/048635 patent/WO2021041989A1/en unknown
- 2020-08-28 JP JP2022513477A patent/JP2022545553A/ja active Pending
- 2020-08-28 CA CA3148990A patent/CA3148990A1/en active Pending
- 2020-08-28 MX MX2022002447A patent/MX2022002447A/es unknown
- 2020-08-28 US US17/638,630 patent/US20220306728A1/en active Pending
- 2020-08-28 AU AU2020335922A patent/AU2020335922A1/en active Pending
- 2020-08-28 CN CN202080076781.6A patent/CN115052630A/zh active Pending
- 2020-08-28 KR KR1020227010317A patent/KR20220061999A/ko unknown
- 2020-08-28 BR BR112022003529A patent/BR112022003529A2/pt unknown
-
2022
- 2022-02-20 IL IL290752A patent/IL290752A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3280675B2 (ja) | 多価dtpポリオワクチン | |
JP2505944B2 (ja) | (S)―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物 | |
JP5781606B2 (ja) | インフルエンザ、一般的な感冒および炎症の治療におけるレボセチリジンおよびモンテルカストの使用 | |
KR20170044211A (ko) | 항체 제제 | |
ES2267591T3 (es) | Combinaciones farmaceuticas que comprenden un antagonista del receptor p2t y melagatran. | |
JP2020073566A5 (zh) | ||
KR100333113B1 (ko) | 헬리코박터피롤리관련위십이지장질환의치료방법 | |
JP2019537555A5 (zh) | ||
JP2016512262A (ja) | 血管炎の処置におけるレボセチリジン及びモンテルカストの使用 | |
JP2014501718A (ja) | ペプチドおよびウイルス・ノイラミニダーゼ阻害剤を含んでなる組成物 | |
JP2020500864A5 (zh) | ||
JP2023523248A (ja) | 顆粒球マクロファージコロニー刺激因子に基づく感染治療 | |
KR20230038644A (ko) | 코로나바이러스 치료를 위한 피르페니돈 | |
JP2022501358A (ja) | Hivの予防のためのインテグラーゼ阻害剤 | |
US7132453B2 (en) | Method of using prostacyclin to treat respiratory syncytial virus infections | |
US11666617B2 (en) | Treatment of warts | |
JPWO2021041989A5 (zh) | ||
WO2014059363A1 (en) | Oral solution formulations of aripiprazole | |
JP2003171266A (ja) | キシリトールを含有する解熱性調剤 | |
CA3176432A1 (en) | Preventative treatment of migraine | |
JP7417339B1 (ja) | アデノウイルス感染又はアデノウイルス感染に伴う疾患の治療 | |
JP2012025734A (ja) | 骨髄異形性症候群を治療するための組成物および方法 | |
US20220362190A1 (en) | Viral inactivation spray and gargling formulation | |
RU2678981C2 (ru) | Композиция от бешенства, содержащая адъювант pika | |
CA3205325A1 (en) | Method for producing blood plasma product useful in the treatment of viral infections characterized by an uncontrolled release of proinflammatory cytokines |